Unknown PHASE4 INTERVENTIONAL 2-arm NCT02331745

RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure

Granulocyte Colony-stimulating Factor(G-CSF) in the Treatment of Hepatic Failure: a Prospective Randomized Controlled Clinical Study

Sponsor: Beijing 302 Hospital

Conditions Alcoholic Liver Disease Hepatitis B Liver Failure

Interventions Granulocyte colony-stimulating factor standard treatment

Updated 6 times since 2017 Last updated: Aug 4, 2016 Started: Oct 31, 2013 Primary completion: Apr 30, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Alcoholic Liver Disease and Hepatitis B, this trial is ongoing. The trial is conducted by Beijing 302 Hospital and has accumulated 6 data snapshots since 2013. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Sep 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Sep 2018 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing 302 Hospital

Data source: Beijing 302 Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China